The HPV Vaccine's 18-Year Payoff
Between 2020 and 2024, not one woman between the ages of 20 and 24 in England died from cervical cancer. Zero.
The first such five-year window in the country's recorded history [231]. The girls who received the HPV vaccine at ages 12 and 13 starting in 2008 are now in their late 20s. Researchers at Queen Mary University of London, publishing in The Lancet, calculated that roughly 23 deaths would have occurred in that age group over those five years without vaccination. About 200 lives have been saved since the program launched. "It's incredible to think that a single jab can almost eliminate a particular type of cancer," said Professor Peter Sasieni, who led the study [231].
What each field noticed (1)
HPV vaccine brings cervical cancer deaths to near zero
The number that stops you is zero. Not "lower" or "significantly reduced" — zero. In every prior five-year period on record, deaths in that age group fell somewhere between five and 27. The decline tracks almost exactly with who was old enough to be in the first vaccinated cohort in 2008. "As vaccinated generations grow older, we'll see many more lives saved from cervical cancer," Sasieni said, calling the current results "the tip of the iceberg" [231].
Read the story





